A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole

A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole

Benznidazole (BZ) is one of the two drugs used for Chagas disease treatment. Nevertheless therapeutic failures of BZ have been reported, which were mostly attributed to variable drug susceptibility among Trypanosoma cruzi strains. ATP-binding cassette (ABC) transporters are involved in a variety of...

Full description

Bibliographic Details
Main Authors:	Bianca Zingales, Rafael Gomes Aquino Araujo, Margoth Moreno, Jaques Franco, Pedro Henrique Nascimento Aguiar, Solange Lessa Nunes, Marcelo Nunes Silva, Susan Ienne, Carlos Renato Machado, Adeilton Brandão
Format:	Article
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 2015-05-01
Series:	Memórias do Instituto Oswaldo Cruz.
Subjects:	Chagas disease benznidazole resistance ABCG transporter T. cruzi strains transcript abundance single nucleotide polymorphisms
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000300433&lng=en&tlng=en

Similar Items

Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole
by: Jair Téllez, et al.
Published: (2019-05-01)

Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
by: Angela Maria Lourenço, et al.

<b>Trypanocidal activity of genotoxic concentration of benznidazole on epimastigote forms of <i>Trypanosoma cruzi</i></b> - 10.4025/actascihealthsci.v34ispec.12337
by: Silvana Marques Araujo, et al.
Published: (2012-12-01)

O transportador ABC de Trypanosoma cruzi TcABCG1 potencialmente envolvido na resistência a benznidazol: características e filogenia.
by: Jaques Franco de Carvalho Junior
Published: (2014)

O transportador ABC de Trypanosoma cruzi TcABCG1 potencialmente envolvido na resistência a benznidazol: características e filogenia.
by: Carvalho Junior, Jaques Franco de
Published: (2014)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the <i>Trypanosoma cruzi</i> Strain
by: Kátia da Silva Fonseca, et al.
Published: (2021-06-01)

Trypanocidal activity of genotoxic concentration of benznidazole on epimastigote forms of Trypanosoma cruzi = Atividade tripanocida da concentração genotóxica do benzonidazol em formas epimastigotas de Trypanosoma cruzi
by: Edilson Nobuyoshi Kaneshima, et al.
Published: (2012-10-01)

Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains
by: Veloso VM, et al.
Published: (2001-01-01)

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
by: Juan Carlos Villar, et al.
Published: (2019-07-01)

Susceptibilidad in vitro a hexadecilfosfocolina (miltefosina), nifurtimox y benznidazole de cepas de Trypanosoma cruzi aisladas en Santander, Colombia
by: Patricia Escobar, et al.
Published: (2009-09-01)

Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol
by: María L. Cafferata, et al.
Published: (2020-08-01)

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV
by: Susana Revollo, et al.
Published: (2019-10-01)

High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala
by: Lucia Brum-Soares, et al.

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS
by: Margarita Bisio, et al.
Published: (2013-09-01)

Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
by: JUAN DIEGO MAYA, et al.
Published: (2004-01-01)

Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
by: Maria Jose Morilla, et al.
Published: (2005-04-01)

Development of dissolution method for benznidazole tablets
by: Ádley Antonini Neves de Lima, et al.
Published: (2009-01-01)

Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens
by: André Pires Antunes, et al.

Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice
by: Renata Siqueira Portella, et al.
Published: (2009-11-01)

Enfermedad de Chagas aguda, en un adulto tratado con benznidazol (Rochagan®) en Costa Rica
by: Víctor M. Montenegro, et al.
Published: (2004-06-01)

Enfermedad de Chagas aguda, en un adulto tratado con benznidazol (Rochagan®) en Costa Rica
by: Víctor M. Montenegro, et al.
Published: (2004-06-01)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
by: María Cecilia Albareda, et al.
Published: (2015-05-01)

Efecto de simvastatina y benznidazol sobre la expresión de moléculas de adhesión y activación de NFKB en células endoteliales humanas infectadas con Trypanosoma cruzi
by: Campos Estrada, Carolina Andrea
Published: (2016)

Adverse systemic reaction to benznidazole
by: María Verónica Pacheco Coronel, et al.

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
by: Girley Francisco Machado-de-Assis, et al.
Published: (2013-11-01)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
by: Priscila Silva Grijó Farani, et al.
Published: (2021-07-01)

Benznidazole levels in blood vary with age in rats
by: Romina Fernanda Bulffer, et al.
Published: (2011-05-01)

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against <i>Trypanosoma cruzi</i>
by: Cauê Benito Scarim, et al.
Published: (2021-06-01)

Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II) Resposta à quimioterapia com benzonidazol de clones isolados da cepa 21SF do Trypanosoma cruzi (biodema Tipo II, Trypanosoma cruzi II)
by: Rozália Figueira Campos, et al.
Published: (2005-04-01)

Prostaglandin F2α synthase in Trypanosoma cruzi plays critical roles in oxidative stress and susceptibility to benznidazole
by: Paola García-Huertas, et al.
Published: (2017-01-01)

Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report
by: Valeria Rita Corrêa, et al.
Published: (2014-06-01)

Etiological drug treatment of human infection by Trypanosoma cruzi Tratamento etiológico por droga da infecção humana pelo Trypanosoma cruzi
by: Guido Carlos Levi, et al.
Published: (1996-02-01)

Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations
by: Douglas de Souza Moreira, et al.
Published: (2018-07-01)

Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná State and from different endemic areas of Brazil
by: Max Jean de Ornelas TOLEDO, et al.
Published: (1997-09-01)

Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
by: Cauê Benito Scarim, et al.

Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity
by: Brito TK, et al.
Published: (2020-02-01)

Improving the solubility of the antichagasic drug benznidazole through formation of inclusion complexes with cyclodextrins
by: José Lamartine Soares Sobrinho, et al.
Published: (2011-09-01)

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
by: Leticia L Niborski, et al.
Published: (2016-06-01)